Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Why Is Biogen (BIIB) Stock Up 40% Today?
Tickers BIIB ESALY
Tags BIIB Market News ESALY
From InvestorPlace
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
Tickers AAPL AMZN BIIB BP
Tags Market News SHEL Media
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
Tickers BIIB ESALY
Tags Movers ESALY Market News
From Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Tickers BIIB ESALY SAVA
Tags Movers SAVA ESALY
From Benzinga
Why Biogen Stock Is Up 40% Today
Tickers BIIB ESALY
Tags BIIB alzheimer's Biotech
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
Tickers BIIB ESALY LLY RHHBY
Tags Alzheimer’s Disease RHHBY General
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
Tickers AGCO BB BIIB CTAS
Tags Eurozone Markets AGCO
From Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Tickers BIIB ESALY
Tags JP:NIK ESALY BIIB
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags ESALY News Aduhelm
From Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
Tickers ESALF ESALY MRK
Tags ESALF ESALY News
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Tickers ESALF ESALY LLY RHHBF
Tags LLY Benzinga Market News
From Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
Tickers BIIB ESALY
Tags ESALY Market News BIIB
From Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags Financing MRK FDA
From Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
Tickers ESALF ESALY MRK
Tags General ESALY News
From Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
Tickers AZN ESALY MRK SGEN
Tags MRK Market News SGEN
From Motley Fool
Is This Biotech Stock a Bad News Buy?
Tickers BIIB ESALY
Tags ESALY Market News Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Tickers AMTI BIIB ESALF ESALY
Tags General ESALF RHHBF
From Benzinga
2 Safe Stocks to Buy in a Bear Market
Tickers AZN ESALY ISRG MDT
Tags AZN ESALY MDT
From Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags ESALF AGEN VERU
From Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Market News FDA Benzinga
From Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
Tickers BIIB ESALY SAGE
Tags ESALY Market News Recent Press Releases
From Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
Tickers ESALY LLY PFE SPX
Tags PFE LLY DK:NOVO/B
From MarketWatch
Is This Biotech Stock Worth the Trouble?
Tickers BIIB ESALY LLY SAGE
Tags Recent Press Releases BIIB SAGE
From Motley Fool
What This Regulatory Approval Could Mean for Merck
Tickers ESALY MRK PFE
Tags ESALY MRK Market News
From Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
Tickers ABIO ESALY IBB IMMP
Tags Offerings Small Cap Biotech
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Phase 2 Trial Market News Benzinga
From Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags General ESALY Briefs
From Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
Tickers BIIB ESALF ESALY
Tags Market News Benzinga Contracts
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags ATHX IBB BTTX
From Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Tickers BIIB CEMI ESALY EYEN
Tags IBB OCGN ESALY
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.